Growth Metrics

Neogen (NEOG) Cash & Equivalents (2016 - 2026)

Neogen has reported Cash & Equivalents over the past 17 years, most recently at $159.9 million for Q1 2026.

  • Quarterly results put Cash & Equivalents at $159.9 million for Q1 2026, up 25.21% from a year ago — trailing twelve months through Feb 2026 was $159.9 million (up 25.21% YoY), and the annual figure for FY2025 was $129.0 million, down 24.39%.
  • Cash & Equivalents for Q1 2026 was $159.9 million at Neogen, up from $145.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for NEOG hit a ceiling of $205.8 million in Q4 2023 and a floor of $42.9 million in Q1 2022.
  • Median Cash & Equivalents over the past 5 years was $138.9 million (2025), compared with a mean of $129.6 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 41.65% in 2022 and later soared 267.05% in 2023.
  • Neogen's Cash & Equivalents stood at $100.0 million in 2022, then skyrocketed by 105.76% to $205.8 million in 2023, then tumbled by 31.85% to $140.2 million in 2024, then grew by 3.64% to $145.3 million in 2025, then increased by 10.02% to $159.9 million in 2026.
  • The last three reported values for Cash & Equivalents were $159.9 million (Q1 2026), $145.3 million (Q4 2025), and $138.9 million (Q3 2025) per Business Quant data.